Clinical Trial Update: Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients

View source ↗

Summary

A completed clinical trial evaluating whether serum ferritin can predict hepatic fibrosis in patients with non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Ain Shams University | Conditions: Non-Alcoholic Fatty Liver Disease | Status: COMPLETED